About Univercells Tech
Univercells Tech is a Healthcare company based in Nivelles (Belgium) founded in 2020 by Jose Castillo and Hugues Bultot, and was acquired by Donaldson Company in June 2023. Intensified biomanufacturing technologies for viral production are developed and manufactured. The company has 74 employees. Univercells Tech offers products and services including scale-Xâ„¢ nexo, scale-Xâ„¢ hydro, scale-Xâ„¢ carbo, NevoLineâ„¢ Upstream, and Skaiaâ„¢ vision application. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Bioreactors. Its legal entity is UNIVERCELLS TECHNOLOGIES.
Company details
Univercells Tech was founded in 2020 in Nivelles, Belgium, by co-founders Jose Castillo and Hugues Bultot. Operations are centered in the biomanufacturing sector, where bioreactors and integrated platforms are designed for viral vector production in advanced therapies. Process intensification and chaining techniques are employed to enhance capacity while minimizing manufacturing space. A range of products is provided to support bioprocessing from initial development through to commercial-scale operations.
- Headquarters Nivelles, Belgium
- Employees 74
- Founders Jose Castillo, Hugues Bultot
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website univercellstech.com
- Social LinkedIn
- Acquired by Donaldson Company (Jun 2023)
- Legal Name Univercells Technologies
- Annual Revenue$20.79 M (USD)18as on Dec 31, 2022
- Net Profit-$8.36 M (USD)-35as on Dec 31, 2022
- EBITDA-$8.36 M (USD)-35as on Dec 31, 2022
- Investors
- Employee Count74
- Acquired byDonaldson Company
(Jun 2023)
Products & Services of Univercells Tech
Univercells Tech offers a comprehensive portfolio of products and services, including scale-X™ nexo, scale-X™ hydro, scale-X™ carbo, NevoLine™ Upstream, and Skaia™ vision application.
Intensified technology for cost-effective viral production processes.
Enables suspension-based viral vector production in fixed-bed systems.
Supports scalable cell culture for biomanufacturing applications.
Integrated solution for automated virus manufacturing processes.
Provides tools for biomass estimation in bioreactor systems.
Investors in Univercells Tech
Univercells Tech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Donaldson Company.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Filtration systems are manufactured and supplied globally by Donaldson Company. | 1915 | donaldson.com | Gurugram, India |
Investor details for Univercells Tech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Univercells Tech
16 people are tracked at Univercells Tech (5 in leadership, 4 in board & advisors, 7 in team); the tracked headcount is 74.
| Name | Role | Group |
|---|---|---|
Jose Castillo | Co-Founder | Leadership |
Hugues Bultot | Co-Founder | Leadership |
Florence Vicaire | Chief Commercial Officer | Leadership |
Sarah Beck | Head, Equipment Development | Leadership |
David Moccia | Sales Director Us/can | Leadership |
Anuv Ratan | Director | Board & advisors |
Matthew T. Gunnison | Director | Board & advisors |
José Castillo | Co-Founder & Director | Board & advisors |
Kugan Sathiyanandarajah | Director | Board & advisors |
Pierre Decock | Design Engineer - Single Use | Team |
Pratik Gajjar | Senior Bioprocess Specialist & Sales Manager (techno Commercial) | Team |
Tatiana Diaz | Inside Sales Manager | Team |
Julien Cardon | Life-cycle Engineering Manager - Single-use | Team |
Saci Iken | Business Development Manager II South Europe / North Africa | Team |
Floriane Cohen | Senior Field Application Specialist & Nevoline Coordinator | Team |
Pierre-Michel Bodson | Single Use Manifold's & Life Cycle Management - Senior Engineer | Team |
Complete people profiles for Univercells Tech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Univercells Tech
2 dated milestones of Univercells Tech across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Univercells Tech is founded.
- Exit Acquired by Donaldson Company.
Web traffic of Univercells Tech
The website of Univercells Tech (univercellstech.com) receives about 2.9K visits a month.
- Monthly visits2.9K
▲ 70.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Univercells Tech
Complete news archive for Univercells Tech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Univercells Tech
Univercells Tech was founded in 2020.
Univercells Tech is headquartered in Nivelles, Belgium. It is registered at Nivelles, Walloon Brabant, Belgium.
Univercells Tech has 74 employees.
Annual revenue of Univercells Tech is $20.79M as on Dec 31, 2022.
Univercells Tech was founded in 2020 in Nivelles, Belgium, by co-founders Jose Castillo and Hugues Bultot. Operations are centered in the biomanufacturing sector, where bioreactors and integrated platforms are designed for viral vector production in advanced therapies. Process intensification and chaining techniques are employed to enhance capacity while minimizing manufacturing space. A range of products is provided to support bioprocessing from initial development through to commercial-scale operations.
Univercells Tech offers scale-Xâ„¢ nexo, scale-Xâ„¢ hydro, scale-Xâ„¢ carbo, NevoLineâ„¢ Upstream, and Skaiaâ„¢ vision application.
Univercells Tech has 1 investor. Key investors include Donaldson Company.
Univercells Tech operates through Univercells Technologies.
Yes. Univercells Tech was acquired by Donaldson Company in June 2023.